0001437749-24-010679.txt : 20240402
0001437749-24-010679.hdr.sgml : 20240402
20240402172938
ACCESSION NUMBER: 0001437749-24-010679
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240328
FILED AS OF DATE: 20240402
DATE AS OF CHANGE: 20240402
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Marshall Dennis E
CENTRAL INDEX KEY: 0001361115
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19709
FILM NUMBER: 24815810
MAIL ADDRESS:
STREET 1: 3500 W. GARRY AVENUE
CITY: SANTA ANA
STATE: CA
ZIP: 92705
FORMER NAME:
FORMER CONFORMED NAME: Marshall Dennis
DATE OF NAME CHANGE: 20060428
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BIOLARGO, INC.
CENTRAL INDEX KEY: 0000880242
STANDARD INDUSTRIAL CLASSIFICATION: CHEMICALS & ALLIED PRODUCTS [2800]
ORGANIZATION NAME: 08 Industrial Applications and Services
IRS NUMBER: 650159115
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 14921 CHESTNUT ST.
CITY: WESTMINSTER
STATE: CA
ZIP: 92683
BUSINESS PHONE: 888 400-2863
MAIL ADDRESS:
STREET 1: 14921 CHESTNUT ST.
CITY: WESTMINSTER
STATE: CA
ZIP: 92683
FORMER COMPANY:
FORMER CONFORMED NAME: NUWAY MEDICAL INC
DATE OF NAME CHANGE: 20030205
FORMER COMPANY:
FORMER CONFORMED NAME: NUWAY ENERGY INC
DATE OF NAME CHANGE: 20010815
FORMER COMPANY:
FORMER CONFORMED NAME: LATIN AMERICAN CASINOS INC
DATE OF NAME CHANGE: 19960520
4
1
rdgdoc.xml
FORM 4
X0508
4
2024-03-28
0000880242
BIOLARGO, INC.
BLGO
0001361115
Marshall Dennis E
14921 CHESTNUT ST.
WESTMINSTER
CA
92683
1
0
Option to Purchase Common Stock
0.35
2024-03-28
4
A
0
64176
A
2024-03-28
2034-03-28
Common Stock
64176
4163685
D
Option to Purchase Common Stock
0.35
2024-03-31
4
A
0
53571
A
2024-03-31
2034-03-31
Common Stock
53571
4217256
D
This Option was granted to Reporting Person to replace an option to purchase 52,536 shares that had been issued to compensate Reporting Person for services to the Issuer and had recently expired unexercised due to a discrepancy between the original exercise price and current Issuer stock price, pursuant to plan adopted by the Issuer's Compensation Committee.
Total reflects the expiration of options to purchase 52,536 shares that recently expired.
This Option was issued to Reporting Person as payment for $18,750 in fees due to Reporting Person by Issuer in exchange for services on its board of directors for the most recently completed quarterly period, pursuant to the Issuer's 2018 Equity Incentive Plan.
/s/ John R. Browning, attorney-in-fact
2024-04-02